scholarly article | Q13442814 |
P819 | ADS bibcode | 2016PLoSO..1146326K |
P356 | DOI | 10.1371/JOURNAL.PONE.0146326 |
P932 | PMC publication ID | 4709087 |
P698 | PubMed publication ID | 26751387 |
P5875 | ResearchGate publication ID | 290157351 |
P50 | author | Martin Steinmetz | Q79983109 |
P2093 | author name string | Sebastian Zimmer | |
Dieter Lütjohann | |||
Georg Nickenig | |||
Catharina Lahrmann | |||
Tobias Asdonk | |||
Enzo Lüsebrink | |||
Alexander O Krogmann | |||
P2860 | cites work | Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. | Q51030792 |
Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice. | Q53072350 | ||
Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. | Q53587595 | ||
Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. | Q54105529 | ||
Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice. | Q54292231 | ||
Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model. | Q54306542 | ||
Activation of Endothelial Toll-Like Receptor 3 Impairs Endothelial Function | Q56998027 | ||
Blocking Toll-Like Receptors 7 and 9 Reduces Postinterventional Remodeling via Reduced Macrophage Activation, Foam Cell Formation, and Migration | Q63915472 | ||
CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen | Q74463505 | ||
Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9 | Q80492358 | ||
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity | Q36990647 | ||
Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice | Q37019912 | ||
Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies | Q38153941 | ||
CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7). | Q38288131 | ||
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration | Q38345478 | ||
HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9. | Q39057962 | ||
Stimulatory type A CpG-DNA induces a Th2-like response in human endothelial cells | Q39494483 | ||
Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation | Q40173384 | ||
Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity | Q40524997 | ||
Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution | Q41265554 | ||
Bacterial DNA signatures in carotid atherosclerosis represent both commensals and pathogens of skin origin | Q42275172 | ||
The activation of liver X receptors inhibits toll-like receptor-9-induced foam cell formation | Q43202380 | ||
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways | Q44807760 | ||
Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock | Q44931090 | ||
A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation | Q46346484 | ||
The Toll-like receptor 9 ligand CPG-C attenuates acute inflammatory cardiac dysfunction | Q48884290 | ||
A Toll-like receptor recognizes bacterial DNA | Q24290668 | ||
Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2 | Q24338906 | ||
Danger signaling in atherosclerosis | Q26852204 | ||
Cholesterol, inflammation and innate immunity | Q28086912 | ||
Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension | Q28541982 | ||
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling | Q29615457 | ||
Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor | Q30747560 | ||
CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs | Q33343610 | ||
Toll-like receptor 9 mediated responses in cardiac fibroblasts | Q34050642 | ||
Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells | Q34083770 | ||
CpG motifs in bacterial DNA trigger direct B-cell activation | Q34307394 | ||
Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells. | Q34400381 | ||
Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. | Q35015661 | ||
Microbial composition of atherosclerotic plaques | Q35031446 | ||
The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling | Q35345969 | ||
The immunobiology of the TLR9 subfamily | Q35810913 | ||
The toll-like receptor 9 agonist, CpG-oligodeoxynucleotide 1826, ameliorates cardiac dysfunction after trauma-hemorrhage | Q36103464 | ||
Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation | Q36370469 | ||
CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling | Q36456832 | ||
TLR9 in health and disease | Q36526346 | ||
In vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction | Q36830961 | ||
Selective roles for toll-like receptors 2, 4, and 9 in systemic inflammation and immune dysfunction following peripheral tissue injury. | Q36896481 | ||
The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling | Q36957263 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
toll-like receptor | Q408004 | ||
P304 | page(s) | e0146326 | |
P577 | publication date | 2016-01-11 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice | |
P478 | volume | 11 |
Q59809916 | BAFF Neutralization Aggravates Atherosclerosis |
Q47737089 | Comparative View of Lung Vascular Endothelium of Cattle, Horses, and Water Buffalo |
Q89738918 | CpG-ODN-mediated TLR9 innate immune signalling and calcium dyshomeostasis converge on the NFκB inhibitory protein IκBβ to drive IL1α and IL1β expression |
Q97884390 | Emerging roles of Toll-like receptor 9 in cardiometabolic disorders |
Q47269144 | GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors. |
Q98291857 | Overexpression of MicroRNA-16 Alleviates Atherosclerosis by Inhibition of Inflammatory Pathways |
Q58702074 | RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy |
Q88424530 | Synergistic effect of co-stimulation of membrane and endosomal TLRs on chicken innate immune responses |
Q99591180 | The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease |
Q28077737 | The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis |
Q64058653 | Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis |
Q41657450 | Toll-Like Receptor-9 (TLR9) is Requisite for Acute Inflammatory Response and Injury Following Lung Contusion |
Q33678336 | Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis |